Trial intelligence / Profile preview

Remimazolam Tosilate vs Propofol for hemodynamic stability during ESD

ChiCTR2000037975Phase 4Recruiting

Sponsor
Department of Anesthesiology, Shanghai Chest Hospital
Start
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing Remimazolam Tosilate with Propofol (2 arms). Primary endpoint: Incidence of intraoperative hypotension. Started Sep 2020; status: recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2000037975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000037975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call